Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
27,848,044
-
Share change
-
+574,486
-
Total reported value
-
$1,621,473,992
-
Put/Call ratio
-
76%
-
Price per share
-
$59.63
-
Number of holders
-
170
-
Value change
-
+$45,891,970
-
Number of buys
-
92
-
Number of sells
-
54
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q4 2019
As of 31 Dec 2019,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,848,044 shares.
The largest 10 holders included
Bellevue Group AG, Meditor Group Ltd, VANGUARD GROUP INC, Pentwater Capital Management LP, BlackRock Inc., STATE STREET CORP, BOXER CAPITAL, LLC, CREDIT SUISSE AG/, WASATCH ADVISORS INC, and Rhenman & Partners Asset Management AB.
This page lists
170
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.